Serial surveillance for CMV replication, with the use of antigenemia or NAT, is a common practice during the early period after transplantation. This diagnostic approach is an integral component in the strategy of preemptive therapy against CMV disease
If you want to change selection, open document below and click on "Move attachment"
- (no access) - CMV ASM.pdf, p13
|status||not read|| ||reprioritisations|
|last reprioritisation on|| ||suggested re-reading day|
|started reading on|| ||finished reading on|